Showing 2,201 - 2,220 results of 2,687 for search '"chemotherapy"', query time: 0.24s Refine Results
  1. 2201

    Influence of Mesalazine on Ferroptosis-Related Gene Expression in In Vitro Colorectal Cancer Culture by Joanna Słoka, Barbara Strzałka-Mrozik, Sebastian Kubica, Ilona Nowak, Celina Kruszniewska-Rajs

    Published 2025-01-01
    “…Its fundamental treatments include surgery and chemotherapy, predominantly utilizing 5-fluorouracil (5-FU). …”
    Get full text
    Article
  2. 2202

    Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy by Shuai Wang, Yongsen Wang, Xuan Wu, Li Yang, Xiaoju Zhang

    Published 2025-02-01
    “…Conclusion Transformed SCLC exhibited poor response to primary SCLC classic chemotherapy and immunotherapy. It carries a worse prognosis. …”
    Get full text
    Article
  3. 2203

    Long noncoding RNA GDIL acts as a scaffold for CHAC1 and XRN2 to promote platinum resistance of colorectal cancer through inhibition of glutathione degradation by Xuan Deng, Lu Chang, Lingyu Tang, Haoqin Jiang, Xiao Xu, Xinju Zhang, Jian Chen, Liu Dong, Qianqian Xu, Ruoshui Cao, Jianbin Xiang, Ming Guan

    Published 2025-02-01
    “…High expression of GDIL in resistant CRC is associated with poor survival and hyposensitivity to chemotherapy. We demonstrate that GDIL boosted GSH levels and enhances clearance of ROS induced by platinum. …”
    Get full text
    Article
  4. 2204

    Machine learning-based prognostic model for patients with anaplastic thyroid carcinoma by Yihan Sun, Da Lin, Xiangyang Deng, Yinlong Zhang

    Published 2025-01-01
    “…And we further ranked the time-dependent features according to their permutation importance and observed that surgery, radiotherapy, and chemotherapy were the most influential predictors initially. …”
    Get full text
    Article
  5. 2205

    Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer by Chen Zhang, Hubin Yin, Tinghao Li, Junrui Chen, Weiyang He, Ke Ren, Bo Li, Xudong Liu

    Published 2025-12-01
    “…Background Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. …”
    Get full text
    Article
  6. 2206

    Harnessing nanotechnology for cancer treatment by Jiajun Zhu, Jiajun Zhu, HaeJu Lee, HaeJu Lee, Ruotong Huang, Ruotong Huang, Jianming Zhou, Jingjun Zhang, Xiaoyi Yang, Wenhan Zhou, Wangqing Jiang, Shuying Chen

    Published 2025-01-01
    “…Nanotechnology has become a groundbreaking innovation force in cancer therapy, offering innovative solutions to the limitations of conventional treatments such as chemotherapy and radiation. By manipulating materials at the nanoscale, researchers have developed nanocarriers capable of targeted drug delivery, improving therapeutic efficacy while reducing systemic toxicity. …”
    Get full text
    Article
  7. 2207

    Targeting Glutathione-S Transferase Enzymes in Musculoskeletal Sarcomas: A Promising Therapeutic Strategy by Michela Pasello, Maria Cristina Manara, Francesca Michelacci, Marilù Fanelli, Claudia Maria Hattinger, Giordano Nicoletti, Lorena Landuzzi, Pier Luigi Lollini, Annamaria Caccuri, Piero Picci, Katia Scotlandi, Massimo Serra

    Published 2011-01-01
    “…Recent studies have indicated that targeting glutathione-S-transferase (GST) isoenzymes may be a promising novel strategy to improve the efficacy of conventional chemotherapy in the three most common musculoskeletal tumours: osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. …”
    Get full text
    Article
  8. 2208

    Objective Clinical and Radiological Response under Sunitinib in a Case of Thigh Hidradenocarcinoma by S. Korbi, H. Rachdi, H. El Benna, N. Mejri, Y. Berrazaga, N. Daoud, S. Labidi, H. Boussen

    Published 2020-01-01
    “…The patient was treated by 3 lines of chemotherapy, 1st by Adriamycin, 2nd by carboplatin-paclitaxel, and then 3rd by oral capecitabine, leading to a stable clinical disease but without a clinical benefit. …”
    Get full text
    Article
  9. 2209

    Evaluating the Accuracy, Quality, and Readability of Online Breast Cancer Information by Elsie A. Valencia, BS, Chandler S. Cortina, MD, MS, FSSO, FACS, Adrienne N. Cobb, MD, MS, Lubna N. Chaudhary, MD, MS, Tracy Kelly, MD, Amanda L. Kong, MD, MS, FSSO, FACS

    Published 2024-09-01
    “…A qualitative analysis on 50 websites was conducted; the first 10 eligible websites for the following search terms were included: “breast cancer,” “breast surgery,” “breast reconstructive surgery,” “breast chemotherapy,” and “breast radiation therapy.” Websites were required to be in English and not intended for healthcare professionals. …”
    Get full text
    Article
  10. 2210

    Mandibular (Gnathic) osteosarcoma: Narrative review emphasizing clinical, radiological, and histopathological correlation by Praveen K. Sharma, Iffath Misbah, J.H.Shazia Fathima, Ajay Lucas Rubben, Jeban Chella Bruce

    Published 2024-06-01
    “…Post-operative reconstruction is essential for restoring function and aesthetics. Chemotherapy is a critical adjunct to surgery, while radiation therapy is reserved for specific cases. …”
    Get full text
    Article
  11. 2211

    Tumor-To-Tumor Metastasis of Poorly Differentiated Gastric Carcinoma to Uterine Lipoleiomyoma by Ryo Kiyokoba, Hiroshi Yagi, Hideaki Yahata, Yoshiaki Kawano, Eisuke Kaneki, Kaoru Okugawa, Kenzo Sonoda, Kiyoko Kato

    Published 2015-01-01
    “…She underwent 16 courses of TS-1/cisplatin chemotherapy, which achieved significant tumor reduction. …”
    Get full text
    Article
  12. 2212

    Cerebellar metastasis from colorectal cancer: a case report by Carla E. Angulo-Rojo, Luis J. Castillo-Gaxiola, Karen Gaxiola-Gastélum, Alma M. Guadrón-Llanos, Javier A. Magaña-Gómez, Diana L. Baldenebro-Félix, Diana L. Baldenebro-Félix

    Published 2025-01-01
    “…Despite extensive treatment, including surgery and chemotherapy, the disease progressed, ultimately leading to the patient’s demise. …”
    Get full text
    Article
  13. 2213

    Short‐ and Long‐Term Efficacy of Hyperbaric Oxygen Therapy in Irradiated Breast Cancer Patients With Long‐Standing Lymphedema: A Prospective Case Series by Imjai Chitapanarux, Siriarrayapa Chachvarat, Patumrat Sripan, Thienchai Pattarasakulchai, Nuttaya Pattamapaspong, Thanat Kanthawang, Montana Buntragulpoontawee

    Published 2025-01-01
    “…All of them received breast surgery and dissection of axillary lymph nodes, chemotherapy, and postoperative radiotherapy. The average duration from the onset of lymphedema to HBO treatment was 9 ± 5.92 years (range 2–17). …”
    Get full text
    Article
  14. 2214

    Primary large B-cell lymphoma of the central nervous system misdiagnosed as autoimmune encephalitis: a case report by Aihui Ren, Guanwen Zeng, Riling Chen, Zhixing Cao, Wenyan Zhuo, Yubin Liang, Yubin Liang

    Published 2025-01-01
    “…The patient was then transferred for high-dose methotrexate chemotherapy but due to lack of regular follow-up, the disease progressed, resulting in cerebral herniation and respiratory failure and ultimately death. …”
    Get full text
    Article
  15. 2215

    Multimodal treatments and the risk of breast cancer-related lymphedema: insights from a nationally representative cohort in South Korea by Sung Hoon Jeong, Seong Min Chun, Miji Kim, Ye Seol Lee, Jisun Kim, Ja-Ho Leigh, Yoon-Hee Choi

    Published 2025-01-01
    “…Abstract Background As the roles of chemotherapy (Chemo) and radiation therapy (Radio) in the definitive treatment of breast cancer have expanded, a broader understanding of the factors associated with breast cancer-related lymphedema (BCRL) has become increasingly essential. …”
    Get full text
    Article
  16. 2216

    PARP inhibitors as therapy for small cell lung carcinoma: A systematic review and meta-analysis of clinical trials by Samuel Pratama, Lowilius Wiyono, Martien Silviandy Setiawan, Brigitta Cindy Lauren

    Published 2024-01-01
    “…Conclusion: The addition of PARPi in the chemotherapy regimen for patients with SCLC results in increased PFS and ORR, with no difference in OS and an increased risk of TEAEs. …”
    Get full text
    Article
  17. 2217

    Tumour heterogeneity and personalized treatment screening based on single-cell transcriptomics by Xinying Zhang, Jiajie Xie, Zixin Yang, Carisa Kwok Wai Yu, Yaohua Hu, Jing Qin

    Published 2025-01-01
    “…Despite advancements in anticancer drugs and optimised chemotherapy regimens that have improved cure rates for malignant tumours, the presence of tumour heterogeneity has resulted in substantial variations among patients in terms of disease progression, clinical response, sensitivity to therapy, and prognosis, posing significant challenges in attaining optimal therapeutic outcomes for each patient. …”
    Get full text
    Article
  18. 2218

    Long-Term Survival in a Patient with Multiple Brain Metastases from Small-Cell Lung Cancer Treated with Gamma Knife Radiosurgery on Four Occasions: A Case Report by Ameer L. Elaimy, Sudheer R. Thumma, Andrew F. Lamm, Alexander R. Mackay, Wayne T. Lamoreaux, Robert K. Fairbanks, John J. Demakas, Barton S. Cooke, Christopher M. Lee

    Published 2012-01-01
    “…For this reason, we present the case of a 70-year-old patient who was diagnosed with multiple brain metastases from small-cell lung cancer five years ago and is currently alive following treatment with chemotherapy for the primary cancer and whole-brain radiation therapy and Gamma Knife radiosurgery on four separate occasions for the neurological cancer. …”
    Get full text
    Article
  19. 2219

    Pancreatic Cancer: Molecular, Biochemical, Chemopreventive, and Therapeutic Aspects by Juan Iovanna, José Luis Neira

    Published 2010-01-01
    “…The presence of occult or clinical metastases at the time of diagnosis, together with the lack of effective chemotherapies, contributes to the high mortality in patients with PC. …”
    Get full text
    Article
  20. 2220

    MicroRNAs in the DNA Damage/Repair Network and Cancer by Alessandra Tessitore, Germana Cicciarelli, Filippo Del Vecchio, Agata Gaggiano, Daniela Verzella, Mariafausta Fischietti, Davide Vecchiotti, Daria Capece, Francesca Zazzeroni, Edoardo Alesse

    Published 2014-01-01
    “…To preserve the genomic integrity, eukaryotic cells need a complex DNA damage/repair response network of signaling pathways, involving many proteins, able to induce cell cycle arrest, apoptosis, or DNA repair. Chemotherapy and/or radiation therapy are the most commonly used therapeutic approaches to manage cancer and act mainly through the induction of DNA damage. …”
    Get full text
    Article